BRIEF published on 12/13/2024 at 12:02, 8 days 7 hours ago Citigroup reduces its stake in GENEURO SA Euronext Paris Sale Of Shares Threshold Crossing GeNeuro SA Citigroup
BRIEF published on 12/13/2024 at 12:02, 8 days 7 hours ago Citigroup réduit sa participation dans GENEURO SA Euronext Paris Franchissement De Seuil Vente D'actions GeNeuro SA Citigroup
PRESS RELEASE published on 12/13/2024 at 11:57, 8 days 7 hours ago Franchissement de seuils Déclaration de franchissement de seuils de Citigroup Global Markets Limited concernant GENEURO SA publiée le 12 décembre 2024 Déclaration Franchissement De Seuils GeNeuro SA Citigroup Global Markets Limited
BRIEF published on 12/06/2024 at 18:35, 15 days ago GeNeuro dévoile son nouveau médicament de précision pour la SLA Médecine De Précision GeNeuro Traitement De La SLA GNK-301 ENVIRONNEMENT HERV-K
BRIEF published on 12/06/2024 at 18:35, 15 days ago GeNeuro's New Precision Medicine for ALS Unveiled Precision Medicine GeNeuro ALS Treatment GNK-301 HERV-K ENV
PRESS RELEASE published on 12/06/2024 at 18:30, 15 days ago Inside Information / Other news releases GeNeuro presents groundbreaking findings on precision medicine for ALS patients with GNK-301 at the 35th International Symposium on ALS/MND. Research highlights potential of targeting HERV-K ENV to transform ALS treatment Precision Medicine ALS GeNeuro GNK-301 HERV-K ENV
PRESS RELEASE published on 12/06/2024 at 18:30, 15 days ago Informations privilégiées / Autres communiqués Nouvelle approche de médecine de précision pour la SLA avec GNK-301 de GeNeuro présentée au 35e Symposium international sur la SLA/MMN Recherche Médecine De Précision GeNeuro SLA GNK-301
BRIEF published on 11/06/2024 at 09:48, 1 month 15 days ago Franchissement de seuils par Invus Public Equities dans GENEURO SA Euronext Paris Augmentation De Capital Franchissement De Seuils GeNeuro SA Invus Public Equities
BRIEF published on 11/06/2024 at 09:48, 1 month 15 days ago Crossing of thresholds by Invus Public Equities in GENEURO SA Euronext Paris Capital Increase Crossing Thresholds GeNeuro SA Invus Public Equities
PRESS RELEASE published on 11/06/2024 at 09:43, 1 month 15 days ago Franchissement de seuils Déclaration de franchissement de seuils par Invus Public Equities, LP. concernant GENEURO SA sur Euronext Paris Euronext Paris Déclaration Franchissement De Seuils GeNeuro SA Invus Public Equities
Published on 12/21/2024 at 01:30, 17 hours 38 minutes ago Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 38 minutes ago iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 3 minutes ago Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/20/2024 at 23:30, 19 hours 38 minutes ago Boron One Announces Extension to Early Warrant Exercise Incentive Program
Published on 12/21/2024 at 00:51, 18 hours 16 minutes ago Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 22 minutes ago EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 57 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:00, 1 day 1 hour ago ARYZTA AG Announces New Board Technology Committee
Published on 12/21/2024 at 12:17, 6 hours 50 minutes ago AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 6 hours 50 minutes ago AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 1 hour ago Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024
